Search | WHO COVID-19 Research Database

1.

Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring among adults in the United States

Hobbi, S.; Moll, K.; Lufkin, B.; Zhou, C.; Shi, X. Y.; Fingar, K. R.; Hu, M.; Sheng, M.; Joyce, J. C.; Burrell, T.; Chillarige, Y.; Beers, J.; Saunders-Hastings, P.; Muthuri, S. G.; Edwards, K. M.; Black, S.; Kelman, J.; Reich, C.; Amend, K.; Beachler, D.; Ogilvie, R.; Secora, A.; Seeger, J.; Lloyd, P.; Thompson, D.; Dimova, R.; Obidi, J.; Anderson, S.; Forshee, R. A.; Wong, H. L.; Shoaibi, A.; Shangguan, S..

Pharmacoepidemiology and Drug Safety ; 31:606-607, 2022.

Article in English | Web of Science | ID: covidwho-2083698

2.

Adjusting for data observation delay in near real-time safety surveillance of COVID-19 vaccines using administrative claims databases

Chillarige, Y.; Hu, M.; Feng, Y. H.; Shi, X. Y.; Zhou, C.; Wong, H. L.; Jiao, Y. X.; Lloyd, P.; Amend, K.; Beachler, D.; Secora, A.; Kline, A. M.; Clarke, T.; Ogilvie, R.; Reich, C.; McMahill-Walraven, C. N.; Seeger, J.; Anderson, S.; Shoaibi, A..

Pharmacoepidemiology and Drug Safety ; 31:26-27, 2022.

Article in English | Web of Science | ID: covidwho-2083499

3.

Combining COVID-19 vaccine data from claims with data from immunization information systems (IIS) to address exposure misclassification: An approach within the FDA biologics effectiveness and safety (BEST) initiative

Bell, E.; Zhou, C.; Schneider, K. L.; Lloyd, P.; Clarke, T.; Yang, G.; Wilkinson, M.; Amend, K.; Myers, E.; Anderson, S.; Shoaibi, A.; Seeger, J.; Wong, H. L..

Pharmacoepidemiology and Drug Safety ; 31:604-605, 2022.

Article in English | Web of Science | ID: covidwho-2083429

4.

Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network

Moll, K.; Hobbi, S.; Zhou, C. K.; Fingar, K.; Burrell, T.; Hernandez-Medina, V.; Alawar, N.; Anderson, S. A.; Wong, H. L.; Obidi, J.; Shoaibi, A..

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research ; 25(7):S463-S463, 2022.

Article in English | EuropePMC | ID: covidwho-1905041

5.

Descriptive epidemiology of adverse events of special interest for COVID-19 vaccines across 7 countries and 4 continents: A multinational network cohort study

Li, X. T.; Ostropolets, A.; Makadia, R.; Shoaibi, A.; Rao, G.; Sena, A. G.; Schuemie, M.; Martinez-Hernandez, E.; Fernandez-Bertolin, S.; Duartes-Salles, T.; Ryan, P.; Hripcsak, G.; Prieto-Alhambra, D..

Pharmacoepidemiology and Drug Safety ; 30:25-25, 2021.

Article in English | Web of Science | ID: covidwho-1381710

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL